Sarepta Therapeutics reported $444.62M in Operating Expenses for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US $ 168.21M 60.27M
Agios Pharmaceuticals AGIO:US $ 100.52M 1.24M
Alnylam Pharmaceuticals ALNY:US $ 416.5M 56.51M
Amgen AMGN:US $ 4.42B 680M
Avrobio Inc AVRO:US 27.77M 1.64M
Biocryst Pharmaceuticals BCRX:US $ 100.25M 374K
Biogen BIIB:US $ 2648.2M 727.1M
Biomarin Pharmaceutical BMRN:US $ 494.65M 112.61M
Bluebird Bio BLUE:US $ 108.92M 13.37M
Capricor Therapeutics CAPR:US $ 7.32M 509.78K
Daiichi Sankyo 4568:JP 245.94B 38.74B
Eli Lilly And LLY:US $ 5277.9M 127.8M
Esperion Therapeutics ESPR:US $ 71.22M 9.39M
Gilead Sciences GILD:US $ 4231M 2162M
Insmed INSM:US $ 153.54M 10.6M
Intercept Pharmaceuticals ICPT:US $ 85.12M 13.73M
IONIS PHARMACEUT IONS:US $ 219.3M 19.88M
Mirati Therapeutics MRTX:US $ 182.57M 2.36M
Moderna Inc MRNA:US 2.3B 463M
Nektar Therapeutics NKTR:US $ 174.42M 33.04M
Neurocrine Biosciences NBIX:US $ 393.5M 86M
Newlink Genetics NLNK:US 8.33M 485K
Novavax NVAX:US $ 668.88M 174.21M
Pfizer PFE:US $ 15640M 148M
Ptc Therapeutics PTCT:US $ 257.89M 22.63M
Regeneron Pharmaceuticals REGN:US $ 1747.3M 40.7M
Sangamo Biosciences SGMO:US $ 75.11M 1.62M
Sarepta Therapeutics SRPT:US $ 444.62M 146.91M
Ultragenyx Pharmaceutical RARE:US $ 230.94M 14.37M
Vertex Pharmaceuticals VRTX:US $ 1089.9M 33.3M
YTE INCY:US $ 656.97M 40.27M